Biotechnology

Berkeley Lights Launches T Cell Receptor Sequencing Kit to Increase Efficiency of T Cell Receptor Discovery

The T Cell Receptor Sequencing Kit (TCRseq Kit) allows users of Berkeley Lights platforms to more efficiently identify, recover, and sequence T cells of interest EMERYVILLE, Calif., March 6, 2020 /PRNewswire/ -- Today, Berkeley Lights, a leader in cell selection, launched their new T Cell Recept...

2020-03-06 03:01 3540

Innovent Biologics Announces First Patient Dosed in the Pivotal Registrational Trial of Pemigatinib in Patients with Advanced Cholangiocarcinoma in China

SUZHOU, China, March 4, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseases, today an...

2020-03-04 08:00 5910

Philips Applauded by Frost & Sullivan for its Thought and Technology Leadership and Patient-centered Innovation in the Radiology Market

Philips leverages state-of-the-art technologies to optimize its broad suite of tools, providing timely insights to support radiologists' workflows SANTA CLARA, California, March 3, 2020 /PRNewswire/ -- Based on its recent analysis of the global market for Artificial Intelligence (AI) for enhanced...

2020-03-03 22:00 1502

China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial Results

BEIJING, March 3, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its fourth quarter and fiscal year 2019 fi...

2020-03-03 21:30 7819

CROMSOURCE Announces a Significant Milestone in Digital Management of Its Projects in Cooperation with Techorizon

VERONA, Italy, March 3, 2020 /PRNewswire/ -- CROMSOURCE announced today the achievement of a significant milestone in the digital management of clinical research projects for their clients. InFebruary 2020 CROMSOURCE initiated the 1000th trial to be managed within the advanced TheClinical digital...

2020-03-03 20:00 2675

NAGASE to Launch Glucosyl Naringin, Citrus-derived Anti-aging Cosmetic Ingredient, on March 31

TOKYO, March 3, 2020 /PRNewswire/ -- NAGASE & CO., LTD. of Tokyo will start on March 31 sales of Glucosyl Naringin, an anti-aging cosmetic ingredient that promotes the production of elastin, an extracellular matrix protein involved in the maintenance of skin elasticity and the formation of elasti...

2020-03-03 16:00 1583

Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug

SONGDO, South Korea, March 2, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the agreement, Samsung Biologics will offer a wide range of services from c...

2020-03-03 03:00 1269

ERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)

Approval is for ERBITUX® in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN Pivotal Phase III study shows significant improvements with ERBITUX® in combination with platinum-based therapy with fluorouracil in response rate, disease progression ...

2020-03-02 15:02 5184

Researchers Worldwide Are Using Berkeley Lights' Beacon Platform To Combat COVID-19

Berkeley Lights' proprietary technology, the Beacon® optofluidic platform, is currently used by researchers across three continents—the U.S.,China, and Australia—to help them find solutions for the Coronavirus EMERYVILLE, Calif., Feb. 29, 2020 /PRNewswire/ -- Berkeley Lights, Inc., a leader in c...

2020-02-29 01:00 3789

LipoTrue S.L and Proya cooperate in developing new anti-wrinkle products

BARCELONA, Spain, Feb. 28, 2020 /PRNewswire/ -- International biotech lab LipoTrue S.L has recently collaborated with leading Chinese cosmetics company Proya Cosmetics Co., Ltd. (SHA: 603605) to develop core technologies for Proya's functional cosmetic products according to the technical cooperati...

2020-02-28 13:33 7730

KAHR Medical Raises $18 Million in Private Funding Round

Funds will be used for advancing the Company's next generation immuno-oncology drug candidates, including lead anti-CD47 product for the treatment of solid tumors through Phase I/II study in addition to advancing preclinical pipeline JERUSALEM, Feb. 26, 2020 /PRNewswire/ -- KAHR Medical

2020-02-26 08:30 2827

InDex Pharmaceuticals Publishes Mechanism of Action Data for Cobitolimod in Scientific Journal

STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the publication of scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate in development for the treatment of moderate to severe ulcerative colitis. The paper, pu...

2020-02-25 15:26 1277

Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Trial of APG-1387 in Combination with Chemotherapy for the Treatment of Advanced Pancreatic Cancer in China

SUZHOU, China and ROCKVILLE, MD., Feb. 24, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has receive...

2020-02-24 22:00 2425

WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321

SHANGHAI, Feb. 23, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its strategic partner Immutep, a biotechnology comp...

2020-02-24 08:00 6135

S-CELL Becomes the First in Asia to Introduce Consumer Epigenetics Testing and is the Most Advanced Test in the World

HONG KONG, Feb. 21, 2020 /PRNewswire/ -- S-CELL, in partnership with Chronomics, is the first company inAsia to introduce Healthspan, the most advanced epigenetic testing service in the world. Chronomics was established in 2017 and later officially launched the epigenetics testing kit in hopes to...

2020-02-21 09:20 2224

Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial

HOUSTON, Feb. 20, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficult-to-treat conditions, today announced it has signed an agreement with Mycenax Biotech for the production of material...

2020-02-20 15:15 1598

Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics

MADISON, Wisconsin, Feb. 20, 2020 /PRNewswire/ -- Nimble Therapeutics, Inc. today announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery and development of novel peptide-based medicines for targets across a range of diseases. The collaboration w...

2020-02-20 01:00 1986

NeuroVive Pharmaceutical AB Year End Report January - December 2019

STOCKHOLM, Feb. 19, 2020 /PRNewswire/ -- Important events in 2019 KL1333            * NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study            * NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study            * NeuroVive compl...

2020-02-19 16:08 6310

Chinese Scientist Unite Together to Tackle With COVID-19

BEIJING, Feb. 19, 2020 /PRNewswire/ -- Reported by Science & Technology Daily: As to the battle against the COVID-19, Chinese Ministry of Science and Technology (MOST) has been launched the program of "Dealing With the Outbreak of COVID-19 Using Science and Technology", a program including four b...

2020-02-19 05:59 2169

Transcenta Achieves Major Milestone in Continuous Perfusion Cell Culture Platform to Provide Industry Leading Productivity and Speed to Manufacturing

SUZHOU and HANGZHOU, China, Feb. 18, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D, regulatory affairs and manufacturing, today announced it has achieved a major milestone in its continuous perfusion cell cult...

2020-02-19 00:00 755
1 ... 297298299300301302303 ... 306